Podcasts about Danaher

EXECUTIVE SUMMARYIn 2026's 'forever layoff' era, women leaders who master continuous improvement leadership outperform peers, reduce their layoff risk, and accelerate promotions. Olaf Boettger's 27-year Kaizen framework — courage, humility, discipline — turns daily small improvements into extraordinary career results.Key stat: Toyota workers are 2x more productive than competitors using this same system.? QUICK TAKEAWAYS•       Continuous improvement leadership doubles your career productivity vs. peers who stop learning•       The 3 capabilities every woman leader needs: courage to name problems, humility to keep learning, discipline to stay consistent•       Kaizen's daily 15-minute team meeting is directly applicable to your own career self-management•       GE's turnaround under Larry Culp proves CI works in any industry — finance, tech, healthcare, or your own career•       In 2026's 'forever layoff' climate, CI skills signal indispensable strategic value to any organizationIf you're a woman leader in 2026, the job market has changed dramatically — and not in your favor. Glassdoor's Worklife Trends report calls it the 'forever layoff': small, rolling cuts that never make headlines but keep talented executives in a constant state of anxiety. Meanwhile, AI is reshaping roles at every level, and the competition for standout positions has never been fiercer.As an executive coach with over 30 years of experience (MA, MFT, PCC) and host of the Women's Leadership Success Podcast — ranked in the top 1.5% globally with over 750,000 downloads — I've interviewed more than 144 of the world's top leadership experts. When I heard Olaf Boettger's approach to continuous improvement leadership, I immediately knew this was the missing framework most women leaders had never considered.Olaf spent 27 years at Procter & Gamble and Danaher — two of the most operationally excellent companies on earth — mastering the Japanese Kaizen philosophy. What he discovered translates directly to career acceleration: the same system that doubled Toyota's worker productivity and powered GE's biggest turnaround in American history can supercharge your leadership brand and make you the candidate no one can afford to pass over. The 2026 Career Reality: Why 'Working Hard' Is No Longer Enough The data is sobering for women leaders right now. According to Glassdoor's 2025 Workplace Trends report, small layoffs — under 50 people — now represent 51% of all job cuts, up from just 38% in 2015. These 'forever layoffs' create cultures of anxiety where talented women question their value daily.At the same time, female manager engagement dropped seven percentage points in 2025 alone — the steepest decline of any group, according to Gallup research. Women leaders are being asked to do more with less, carrying teams through AI disruption and RTO mandates, while their own career advancement stalls.The traditional answer — work harder, be more visible, volunteer for every high-profile project — simply isn't scaling. In a market where 45% of employers rate the job outlook as 'fair' at best, you need a completely different strategy. You need continuous improvement leadership. ? Ready to transform your career trajectory?  Download our FREE Leadership Branding Blueprint Accelerator and discover:•       A proven system to document your impact and accelerate promotions•       How to build a leadership brand that makes you the obvious choice•       A measurable framework for expanding your organizational influence•       Strategic positioning for high-visibility, career-defining initiatives•       The same approach Sabrina uses with Fortune 500 executives to 3x their promotion speed? GET YOUR FREE LEADERSHIP BRANDING BLUEPRINT ACCELERATOR What Is Continuous Improvement Leadership? The Kaizen Framework Explained Continuous improvement — known in Japanese as Kaizen, meaning 'change for the better' — originated at Toyota nearly 90 years ago. After World War II, with limited resources and a need to compete globally, Toyota developed a system to extract maximum quality and efficiency from every process. That system, now called the Toyota Production System, became the foundation of what we know as Lean, Six Sigma, and the Danaher Business System.For women leaders, continuous improvement leadership means applying these same principles to your career, your team, and your organization. It is not a one-time initiative or a January resolution. It is a daily practice — a permanent operating system.The Three Foundation PrinciplesOlaf distills continuous improvement leadership into three core principles:Kaizen — The belief that there is always a better way. This is not about being self-critical; it is about being growth-oriented. Every interaction, presentation, and leadership decision is an opportunity to iterate and improve.Go to Gemba — Go to the real place. Stop relying on slide decks and secondhand reports. As a leader, this means visiting your stakeholders, understanding what your team actually experiences day-to-day, and staying close to the work that creates value.Customer focus — Always anchor to what your 'customer' values. In a career context, your customers are your executive stakeholders, your team, and the business outcomes you're hired to deliver. Everything you do should be filtered through: does this add value for them?The Three Capabilities That Determine SuccessAccording to Olaf, your mindset determines everything. Leaders who succeed with continuous improvement possess three non-negotiable capabilities:CapabilityWhat It Looks Like in PracticeWhy Women Leaders Need It NowCOURAGEHonestly naming when your performance or your team's is 'red' — even when the culture rewards positivity over truth.In 2026's performance-pressured environment, leaders who surface problems first are seen as strategic — not weak.HUMILITYStaying open to learning regardless of your experience level. As Olaf says: the best leaders he's known, including P&G's CEO A.G. Lafley, were the most humble.Imposter syndrome tempts women to prove they already know everything. Humility is the counterintuitive superpower.DISCIPLINEShowing up for improvement consistently — not just in January. Committing to the decade, not the quarter.Career advancement compounds. The women who stand out in 2026 are those who have been quietly improving for years. The Business Case: What Continuous Improvement Leadership Actually Delivers For skeptics — and Olaf acknowledges that many leaders initially resist this approach — the numbers make a compelling argument. Toyota, the originator of this system, generates roughly twice the revenue per employee compared to its nearest competitors. Danaher, where Olaf spent the bulk of his career, has sustained approximately 15–16% compound annual growth for 40 consecutive years.The most visible example is GE's transformation under Larry Culp — the former Danaher CEO who took over when GE was in deep financial trouble. Using continuous improvement as the operating backbone, Culp and his teams executed what many consider one of the greatest corporate turnarounds in American business history, eventually splitting GE into three highly successful independent companies.On a practical level, Olaf shared a specific case study from a Danaher acquisition: a company delivering orders on time just 50% of the time. Using CI methodologies, that number rose to 95%. For context, if Amazon delivered your packages on time half the time, you'd stop using Amazon. A 45-percentage-point improvement is not incremental — it's transformational. TRY THIS NOW (10 Minutes)Apply Olaf's Red/Green method to your career right now: Identify one goal you have for your career this quarter (promotion, salary increase, high-visibility project).Set a specific target. Write your current actual. Color code it: are you green (on track) or red (below target)? If red — write one sentence explaining why.Then write one action you will take this week to close the gap. That's continuous improvement leadership in action. Do this every Monday.  How to Apply Continuous Improvement Leadership to Your Career in 2026 The beauty of Kaizen is that it scales from a Toyota factory floor to your personal career strategy. Here's how to translate Olaf's framework into your daily leadership practice:The 15-Minute Daily Leadership HuddleAt every Danaher facility, teams hold a 15-minute standing meeting every morning. They review five metrics — safety, quality, delivery, inventory, productivity — and ask: are we red or green? If red, why? Who does what by when?For your career, your five metrics might be: stakeholder relationships, project delivery, skill development, visibility, and team performance. A daily or weekly 10-minute self-check asking those same questions creates the discipline of continuous improvement at the individual level.Visual Management for Your CareerOlaf emphasizes making performance visible. In organizations, this means color-coded boards. For your career, this translates to maintaining a simple achievement tracker — a running document of your wins, metrics, and impact — that you review weekly. This directly feeds your Leadership Branding Blueprint and becomes the evidence base for promotion conversations.The Growth Mindset + Kaizen ConnectionOlaf's PhD research connected him deeply to Carol Dweck's work on fixed vs. growth mindsets. Dweck's research demonstrates that individuals who believe abilities can be developed through dedication consistently outperform those who believe talent is fixed. Continuous improvement is the operational expression of growth mindset — it gives you the system that turns that belief into measurable career results. Your 7-Step Continuous Improvement Career Action Plan Step 1 (10 min): Define your career target.

Vom Silicon Valley mit zwei Exits im neunstelligen Bereich direkt in die Produktionshallen des deutschen Fleischerhandwerks: Dieser radikale Wechsel steht für die Suche nach echter unternehmerischer Substanz fernab von überromantisierten Start-up-Hypes. Es ist die bewusste Entscheidung für einen Markt, der durch gnadenlosen Preisdruck und komplexe Strukturen geprägt ist, aber gerade deshalb enorme Chancen für diejenigen bietet, die bereit sind, den sprichwörtlichen Schmerz im Prozess auszuhalten.Mein Gast ist Josef Brunner, Founder & CEO von NutriUnited. Wir sprechen darüber, wie man sich mit Premium-Nischen vom Diktat der großen Handelsketten löst, warum eine Buy & Build-Strategie im Handwerk eine völlig neue Logik erfordert und weshalb am Ende der echte Cashflow die einzige Kennzahl ist, die wirklich über die Wettbewerbsfähigkeit eines Unternehmens entscheidet.Wir beleuchten in dieser Episode:wie Buy & Build im Handwerk funktioniert,die Logik hinter dem Wechsel aus dem Silicon Valley,Vorteile privater Gesellschafter gegenüber großen Fonds,Strategien gegen den Preisdruck durch gezielte Nischenthemen,warum radikale Ehrlichkeit zu sich selbst der wichtigste Erfolgsfaktor ist,und vieles mehr...Viel Spaß beim Hören!***Timestamps:(00:00:00) Intro(00:03:57) Das handwerkliche Fundament in der Tech-Welt(00:05:17) Werte aus der elterlichen Backstube(00:06:41) Kritik an der überromantisierten Start-up-Welt(00:08:37) Meilenstein JouleX und der Exit an Cisco(00:11:50) Energiemanagement-Software für Rechenzentren(00:15:13) Erfahrungen als Investor nach den großen Exits(00:17:23) Herausforderungen ohne operative Verantwortung(00:19:14) Selbstreflektion beim Wandern und der Weg zum ersten Buch(00:20:44) Follow the Pain und Kreativität: Einblick in seine zwei Bücher(00:22:07) Kontakt zur Familie Obama und Charity-Impact(00:24:14) Kriterien für unternehmerische Wohltätigkeit(00:26:56) Einstieg in den Food-Markt und Portfoliocheck(00:31:47) Vorstellung und Geschäftsmodell von Nutri United(00:35:24) Eigenständigkeit vs. Synergien im Verbund(00:39:26) Strategischer Fokus auf Immobilien und Kontrolle(00:40:54) Fundraising und Auswahl der Investoren-Gruppe(00:43:21) Zielbild für Profitabilität und Marktwachstum(00:49:49) Warum so viele lokale Lebensmittelproduzenten scheitern(00:54:22) Wettbewerb mit Eigenmarken und Nischenbildung(01:00:17) Vorbilder wie Constellation Software und Danaher(01:04:02) Cashflow-Management und operative Agilität(01:08:56) Langfristige Perspektive ohne Exit-Druck***Alle Links zur Folge:Kai Hesselmann auf LinkedIn: https://www.linkedin.com/in/kai-hesselmann-dealcircle/CLOSE THE DEAL auf LinkedIn: https://www.linkedin.com/company/closethedeal-podcastJosef Brunner auf LinkedIn: https://www.linkedin.com/in/josef-brunner-85203915/NutriUnited auf LinkedIn: https://www.linkedin.com/company/nutriunited/Website CLOSE THE DEAL: https://dealcircle.com/ClosetheDeal/Folge 112 zum Thema Food M&A mit Investec: https://dealcircle.com/ClosetheDeal/episoden/112-food-beverage-ma-florian-ismer-juergen-schwarz-investec/***AMBER und DUB.de sind die Plattformen für sichere Unternehmensnachfolgen. Schaut vorbei, wenn ihr euer Unternehmen schnell, sicher und kostenfrei zum Verkauf inserieren wollt oder als Käufer auf der Suche nach passenden Deals seid:www.amber.dealswww.dub.de***Du bist M&A-Berater im Small- oder Midcap-Segment und suchst einen Überblick über alle relevanten Deals? Jetzt schnell den

Gregory J. Scaven, CEO, Board Director, Partner, and currently President at Scaven Enterprises, LLC, brings over 30 years of technical engineering leadership and more than 20 years as a P&L leader to this conversation about problem-solving. With deep expertise in pyrotechnics, explosives, and propellants across automotive, aerospace, and defense industries, Greg shares how his approach to problem-solving evolved from the lab to the boardroom. Greg's introduction to problem-solving came through the lens of high-reliability engineering, where devices that "go boom" must do so only when intended. Working in an industry demanding “six-nines” reliability or better, he learned the discipline of corrective action processes, where finding the true root cause wasn't optional. Greg emphasizes that his early training taught him to demonstrate the ability to turn failure modes on and off, then prove the effectiveness of preventative actions. This rigorous foundation shaped everything that followed. The transition from engineer to business leader brought formal problem solving training through the Danaher Business System. Greg describes how Danaher focused on training leadership teams, not just front-line workers, because problem solving is a critical leadership skill. The emphasis was revolutionary for him: spend 70% of your time defining what the problem actually is. Greg explains that coaching teams to frame problems correctly became more important than diving into technical details, and he learned to limit his organization to no more than three major problems at any time, integrating them into regular leadership reviews. Throughout the conversation, Greg returns to a central theme: critical thinking matters more than following forms. He cautions against becoming a slave to any tool, insisting the power lies in the thinking process itself. When young engineers worry about filling out corrective action paperwork, Greg redirects them to focus on what they've learned. He consistently asks teams to reframe their problem statements as new learning emerges, recognizing that the problem definition itself can evolve. Greg draws a clear distinction between what he calls "cause problems" and "creative problems." As an engineer, he dealt with cause problems where scientific rationale could explain failures through tolerance stack-ups and environmental conditions. As a P&L leader, he faces creative problems like sales shortfalls, where turning failure modes on and off isn't possible. This is where experimentation becomes powerful. Greg encourages teams to quickly test their top three ideas, look for early returns, and double down on what works while abandoning what doesn't. Creating a learning culture under P&L pressure requires deliberate effort. Greg believes great businesses are naturally curious, filled with people who aren't afraid when experiments fail. He looks for teams that iterate without waiting for permission, teams that come to him saying, "We tried this, it didn't work, so here's what we're doing next." That's his definition of success. Greg emphasizes accountability for follow-through rather than results, building on concepts from his military background around the commander's intent. Teams that understand the big picture, maintain discipline, and show bias for action don't wait for scheduled reviews when critical issues arise. Greg's approach reveals how curiosity, discipline, and real-time responsiveness create problem-solving cultures that deliver. His journey from engineering to executive leadership demonstrates that while the problems change, the principles of critical thinking, experimentation, and learning remain constant. To connect with Greg or learn more about his work, visit his LinkedIn profile at www.linkedin.com/in/gjscaven.

In der heutigen Folge sprechen die Finanzjournalisten Lea Oetjen und Nando Sommerfeldt über einen Dämpfer für Qiagen, die 200-Milliarden-Dollar-Investitionen von Micron und ein weiteres Kapitel im Kampf um Warner Bros Discovery. Außerdem geht es um Vonovia, Aroundtown, Nvidia, Meta, Paramount Skydance, Netflix, Norwegian Cruise Line, Danaher, Masimo, Südzucker, Palo Alto Networks, Deutsche Telekom, Orange, Swisscom, AT&T, SAP, Alphabet, Amazon, Vodafone, Nokia, Ericsson und iShares STOXX Europe 600 Telecommunications (WKN: A0H08R). Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Der Börsen-Podcast Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Bei unserem Partner Scalable Capital gibt's jetzt nicht nur das unserer Meinung nach beste Broker-Angebot in Deutschland. Ihr kriegt auch noch 25 € vom Scalable-ETF, wenn ihr ein neues Konto eröffnet und nutzt. Dazu unterstützt ihr auch noch diesen Podcast. Mehr Infos gibt's hier. Aktivisten stürmen die Börsen: Elliott x Norwegian Cruise Lines, Starboard x TripAdvisor, Jana x Fiserv. Infleqtion-IPO, Raspberry Pi als KI-Geheimtipp, Compass Pathways mit Psilocybin. Warner Bros. x Paramount, Masimo x Danaher. ServiceNow x Management. Hat Bayer (WKN: BAY001) gestern die Lösung der Glyphosat-Krise gefunden? Und wieso steigt die Aktie immer weiter? Wir klären auf. Das ganze Interview mit Bill Anderson zum Bayer-Turnaround findet ihr hier: https://www.youtube.com/watch?v=tAxTJCDPQ08. Diesen Podcast vom 18.02.2026, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

Carl Quintanilla, David Faber and Michael Santoli led off the show with continuing weakness in tech, software and other sectors in wake of fears about AI. Warner Bros. Discovery says it will restart deal talks with Paramount Skydance despite urging shareholders to back Netflix's takeover offer. Ford refutes reports that it has asked the Trump Administration to allow Chinese EV technology into the U.S. — hear what Ford executives told CNBC about what the automaker is doing when it comes to joint ventures. Also in focus: Amazon's nine-session losing streak, Apple's podcast push, the stocks rising on activism moves, Danaher to buy Masimo in a $10 billion deal, why "The Late Show" host Stephen Colbert is slamming CBS. Squawk on the Street Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

US equity futures are under pressure following a mostly higher Friday close, with Asian markets mixed in holiday-thinned trade and European equities trading modestly firmer. Markets continue to rotate beneath the surface. The broadening-out trade remains intact, supported by cooler headline inflation and a rate rally, though AI-related concentration risk and scrutiny around large-cap tech valuations remain an overhang. Investors are balancing softer consumer data against still-solid labor conditions and stable earnings trends, while positioning and sentiment appear less stretched than earlier in the year. Attention now shifts to the upcoming batch of economic releases and policy signals, with inflation trends and Fed communication remaining central to the outlook.Companies Mentioned: Masimo, Danaher, Norwegian Cruise Line, Tesla

Vuelven a la negociación Bolsas americanas con caídas en los futuros sobre sus índices. Los riesgos potenciales de los actores chinos de la IA se suman a la incertidumbre. Ayer Alibaba presentó un nuevo modelo de IA, Qwen 3.5, diseñado para ejecutar tareas complejas de forma independiente. Nvidia está en rojo en preapertura pese a buenos recomendaciones. Warner rechaza la oferta de adquisición revisada de Paramount. Da a los estudios una semana para negociar un mejor acuerdo. Ambas empresas suben. Juego dan fondos activistas en Norwegian Cruise y Fiserv. La operación del día la protagoniza Danaher sobre Masimo. Casi 10.000 millones de dólares. Desde la Fed hablan Michael Barr y Mary Daly. En lo geopolítico, se observa evolución de las conversaciones nucleares entre Estados Unidos e Irán. Y atentos en lo comercial al Tribunal Supremo. El viernes podría anunciarse un veredicto sobre los aranceles de Trump. Nos analiza el mercado esta hora Víctor Peiro, de GVC Gaesco.

Richard Lucas hosts a compelling discussion with celebrated British entrepreneur and author David Cleevely. In this insightful podcast, Richard and David dive into Cleevely's book, 'Serendipity: It Doesn't Happen by Accident,' exploring how environments can be engineered to foster luck. Richard guides the conversation as David explains the puzzle that inspired the book: why significant entrepreneurial ventures repeatedly emerge from seemingly chance encounters in hubs like Cambridge. They discuss the characteristics, systems, and culture—including the crucial role of values of generosity and kindness—that enhance the likelihood of serendipitous, high-impact collaborations. David Cleevely's book, 'Serendipity: It Doesn't Happen by Accident,' explores the idea that environments can be engineered to foster luck, leading to entrepreneurial success through serendipitous, high-impact collaborations. LinksHis book 'Serendipity: It Doesn't Happen by Accident” is available here and from all major booksellers,David Cleevely CBE FREng, FIET is the Chairman of the Raspberry Pi Foundation. He is the founder of telecoms consultancy Analysys (acquired by Datatec International in 2004). co-founded the web based antibody company Abcam (ABC.L) with Jonathan Milner and was Chairman until November 2009 which was acquired by Danaher for US$5.7 billion in 2023. He has co-founded several other companies and is Chairman of two of them..He has been active in promoting Cambridge. He was a prime mover behind Cambridge Network, co-founder of Cambridge Wireless, co-founder and Chairman of Cambridge Angels, Founding Director of the Centre for Science and Policy at the University of Cambridge and Vice Chair of the Cambridgeshire and Peterborough Independent Economic Commission. Other policy work has included membership of the IET Communications Policy Panel, the Ofcom Spectrum Advisory Board and the Enterprise Committee and the National Engineering Policy Group at the Royal Academy of Engineering. From 2001 to 2008, he was a member of the Ministry of Defence Board overseeing information systems and services (DES-ISS, formerly the Defence Communications Services Agency). In addition to Raspberry Pi, his charitable work includes the Cambridge Science Centre, which he helped set up and fund in 2013 and continues as Chair. Richard Lucas, the host of this NBN channel, is founder of CAMentrepreneurs—a network supporting entrepreneurship globally among Cambridge University Alumni and others through locally led chapters. CAMentrepreneurs - Peter Cowley legacy  Books and articles mentioned in the podcast Connected: The Surprising Power of Our Social Networks and How They Shape Our Lives by James H. Fowler PhD (Author), Nicholas A. Christakis The Strength of Weak Ties Mark S. Granovetter Gov. Pritzker Commencement Address: Kindness is intelligence Cambridge Angels Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

APAC stocks traded mixed with an early positive bias seen following the mostly constructive handover from Wall Street, although some cautiousness began to seep through ahead of looming key risk events.China is said to have approved the first batch of NVIDIA's (NVDA) H200 AI chips for import, with sources noting that China has granted approval for the import of several hundred thousand H200 AI chips, later reported to be over 400,000.ANZ shifted its RBA call, in which it now sees a 25bps hike at next week's RBA meeting following the mostly hotter Australian CPI report overnight. European equity futures indicate a firmer cash market open with Euro Stoxx 50 +0.6% following earnings from ASML. Euro Stoxx 50 cash finished with gains of 0.6% on Tuesday.Looking ahead, highlights include New Zealand Trade (Dec), Fed Policy Announcement, BoC Policy Announcement, BCB Policy Announcement. Speakers include ECB's Elderson & Schnabel, BoC's Macklem, Fed Chair Powell. Supply from Germany & US. Earnings from Microsoft, Meta, Tesla, Lam, ServiceNow, IBM, GE Vernova, AT&T, Starbucks, VF Corp, Danaher & AS.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

Richard Lucas hosts a compelling discussion with celebrated British entrepreneur and author David Cleevely. In this insightful podcast, Richard and David dive into Cleevely's book, 'Serendipity: It Doesn't Happen by Accident,' exploring how environments can be engineered to foster luck. Richard guides the conversation as David explains the puzzle that inspired the book: why significant entrepreneurial ventures repeatedly emerge from seemingly chance encounters in hubs like Cambridge. They discuss the characteristics, systems, and culture—including the crucial role of values of generosity and kindness—that enhance the likelihood of serendipitous, high-impact collaborations. David Cleevely's book, 'Serendipity: It Doesn't Happen by Accident,' explores the idea that environments can be engineered to foster luck, leading to entrepreneurial success through serendipitous, high-impact collaborations. LinksHis book 'Serendipity: It Doesn't Happen by Accident” is available here and from all major booksellers,David Cleevely CBE FREng, FIET is the Chairman of the Raspberry Pi Foundation. He is the founder of telecoms consultancy Analysys (acquired by Datatec International in 2004). co-founded the web based antibody company Abcam (ABC.L) with Jonathan Milner and was Chairman until November 2009 which was acquired by Danaher for US$5.7 billion in 2023. He has co-founded several other companies and is Chairman of two of them..He has been active in promoting Cambridge. He was a prime mover behind Cambridge Network, co-founder of Cambridge Wireless, co-founder and Chairman of Cambridge Angels, Founding Director of the Centre for Science and Policy at the University of Cambridge and Vice Chair of the Cambridgeshire and Peterborough Independent Economic Commission. Other policy work has included membership of the IET Communications Policy Panel, the Ofcom Spectrum Advisory Board and the Enterprise Committee and the National Engineering Policy Group at the Royal Academy of Engineering. From 2001 to 2008, he was a member of the Ministry of Defence Board overseeing information systems and services (DES-ISS, formerly the Defence Communications Services Agency). In addition to Raspberry Pi, his charitable work includes the Cambridge Science Centre, which he helped set up and fund in 2013 and continues as Chair. Richard Lucas, the host of this NBN channel, is founder of CAMentrepreneurs—a network supporting entrepreneurship globally among Cambridge University Alumni and others through locally led chapters. CAMentrepreneurs - Peter Cowley legacy  Books and articles mentioned in the podcast Connected: The Surprising Power of Our Social Networks and How They Shape Our Lives by James H. Fowler PhD (Author), Nicholas A. Christakis The Strength of Weak Ties Mark S. Granovetter Gov. Pritzker Commencement Address: Kindness is intelligence Cambridge Angels Learn more about your ad choices. Visit megaphone.fm/adchoices

Guest BioHector Barresi is a fractional Chief Product Officer at CXO Partners, with a deep background in launching innovative B2B technologies across global industrial giants including Honeywell, GE, and Danaher. With a focus on automation, AI, IoT, and wireless technologies, Hector has led the development of multiple products that went on to become billion-dollar businesses. Known for creating new categories from scratch, Hector now works with mid-market companies to drive innovation and go-to-market strategy, leveraging cutting-edge tools like AI to fine-tune product messaging, identify market opportunities, and scale efficiently.TakeawaysBreakthrough products must solve real, validated customer problems.Success begins at product inception—with deep customer conversations.New tech markets require education, storytelling, and demonstration.A superior product still needs the right audience and message fit.AI accelerates customer research and message personalization.Trust is essential: avoid over-automated, generic AI outreach.Tailoring your message to each persona and market is critical.Avoid common launch failures by aligning product, message, and target.Chapters 00:00 Welcome to FutureFuzz and Intro to Hector 00:40 Hector's Background at Honeywell, GE, and CXO Partners 01:40 The Challenge of Launching New Tech Products 02:16 The Right Way to Launch Breakthrough Innovation 04:45 Creating Demand When Customers Don't Know They Need It 06:04 Case Study: Wireless Sensors at Honeywell 07:26 Common Mistakes When Launching Tech Products 08:00 Importance of Targeting the Right Persona with the Right Message 10:55 How AI is Reshaping Product Marketing 13:20 Humanizing AI Use in B2B Storytelling 16:30 Why AI-Generated Messaging Can Backfire 17:40 When AI Helps vs. When It Hurts 20:13 How to Connect with HectorLinkedInFollow Hector Barresi on LinkedIn Follow Vince Quinn on LinkedIn Hashtags#CreatingMarkets #EmergingTech #ProductInnovation #FractionalCPO #AIInMarketing #WirelessSensors #HoneywellSuccess #B2BStrategy #GoToMarket #CustomerCentricDesign #FutureFuzz #TechLeadership #CXOPartners #TrustInTech #IndustrialInnovation #AIandProductMarketing #Innovation #Marketing #Technology #AI #Product #Leadership

Dementia is becoming one of healthcare's most difficult problems to ignore. As the population ages, more families are finding themselves responsible for loved ones who can no longer manage their own care, communicate symptoms clearly, or navigate the healthcare system. Research shows that people living with dementia are hospitalized far more often than those without it—even when age and other medical conditions are taken into account—fueling a cycle of stress, confusion, and hospital visits that are often avoidable with the right support in place.That raises a simple but uncomfortable question: if people living with dementia can't meaningfully engage with the healthcare system on their own, why do we keep designing care models that expect them to?That question sits at the heart of this episode of Highway to Health, hosted by David Kemp, featuring Dirk Soenksen, CEO of Ceresti Health. Together, they explore why family caregivers—not patients—are the most important and overlooked participants in dementia care. The conversation looks at what actually happens inside the home, how caregivers make daily decisions that affect outcomes, and why supporting them can improve quality of life while reducing strain on the healthcare system.Top insights from the talk…Why traditional patient engagement doesn't work for dementia: Cognitive impairment makes it unrealistic to rely on patients to self-report symptoms or manage care, often leaving them disconnected from timely medical support.How caregivers become the real care coordinators: When caregivers are educated and supported, they're better equipped to recognize changes, respond early, and work effectively with primary care physicians.What a caregiver-first model changes for the system: Ceresti Health's approach has shown meaningful reductions in avoidable hospitalizations, saving roughly $6,000 per patient per year while helping people remain at home longer.Dirk Soenksen is a healthcare executive and entrepreneur with a long track record of founding, scaling, and commercializing technology-enabled care and diagnostics companies. He is the co-founder and CEO of Ceresti Health, where he leads a caregiver-enabled dementia care model that delivers proven cost savings for Medicare Advantage plans, ACOs, and PACE programs, and participates in CMS's GUIDE model. Previously, he founded and scaled Aperio into a global leader in digital pathology—raising over $50M and leading the company through FDA clearances and a successful acquisition by Danaher—after earlier leadership roles in digital health, medical technology, and engineering.

 journalist with the Clare Champion has recently published a new Book on the people that worked in Ardnacrusha power station called Powerful People. He joined Pat and Anthony on the phone to discuss the book. Originally broadcast Live from the SBCR Studio on 29th November 2025 as part of Saturday Chronicle hosted by Pat O'Brien and Anthony Lenihan.  Saturday Chronicle is Sponsored by JAMES M NASH AND DERG KITCHEN DESIGN http://dergkitchendesign.ie Message or what's app the studio on 089 2582647 or email sbcrstudio@gmail.com

About Ajay Gannerkote:Ajay Gannerkote is a global healthcare leader with deep experience spanning life sciences, medical devices, and healthcare services. Now serving as president of Integrated DNA Technologies (IDT), a Danaher company, he oversees the organization's growth and strategic direction from Redwood City, California. Before IDT, he led Siemens Healthineers' global ultrasound business as president and head, steering a complex, vertically integrated operation across more than 30 countries. Under his leadership, the business moved from negative growth and margins to strong, sustainable performance, becoming an industry leader in AI-driven clinical technology. Prior to that, he served as Director at KKR Capstone, where he co-led healthcare operations, drove large-scale transformations for portfolio companies, and created significant enterprise value across services and medical device sectors. Ajay spent more than a decade at McKinsey & Company as a partner in the Global Medical Products practice, advising Fortune 500 companies on product development, commercialization, operations, growth strategy, and large-scale turnarounds. Earlier in his career, he held leadership roles at Federal-Mogul, Cambridge Technology Partners, and Infosys, building a foundation in operations, technology, and global business integration. He holds an MBA in Corporate Strategy and Marketing from the University of Michigan's Ross School of Business and a bachelor's degree in Electronics and Telecommunications Engineering from the University of Mysore.Things You'll Learn:Genomic technologies, such as NGS and MRD, are enabling earlier cancer detection, sometimes years ahead of traditional diagnostic methods. This early visibility allows clinicians to intervene sooner and build more personalized treatment strategies.Precision medicine is rapidly maturing as high-quality genomic data becomes central to diagnosis, monitoring, and therapy planning. The next era of oncology will rely heavily on personalized, data-driven decisions.Collaboration across industry, researchers, and regulatory bodies is essential for breakthrough medical innovations. A recent case of a rare disease demonstrates how a coordinated effort can compress the journey from diagnosis to therapy into just a few months.Custom manufacturing and high-quality reagents are critical enablers of clinically reliable genomic insights. Tailored solutions allow researchers and clinicians to analyze tumor-specific markers with greater accuracy and confidence.Strong leadership in genomics requires trust, transparency, and a willingness to challenge assumptions. Ajay's “obligation to dissent” principle encourages continuous innovation and pushes teams to think beyond the status quo.Resources:Connect with and follow Ajay Gannerkote on LinkedIn.Follow Integrated DNA Technologies on LinkedIn and visit their website.

Pat Dorsey gilt als einer der prägenden Investmentdenker unserer Zeit. Als ehemaliger Director of Equity Research bei Morningstar entwickelte er das Konzept der „Economic Moats“. Also der wirtschaftlichen Burggräben, und schuf damit ein Bewertungsmodell, das bis heute die Analyse von Qualitätsunternehmen prägt. Sein Ansatz verbindet die Idee nachhaltiger Wettbewerbsvorteile mit einem klaren Blick auf Kapitalallokation und Reinvestitionsmöglichkeiten. Diese drei Prinzipien, „Economic Moats“, „Runways for Reinvestment“ und „Superior Capital Allocation“, bilden den Kern seines Investmentstils. Anhand seines aktuellen Portfolios mit Beteiligungen an Unternehmen wie Danaher, Meta Platforms oder ASML zeigt sich, wie konsequent Dorsey diese Philosophie umsetzt. Er setzt auf konzentrierte Portfolios hochwertiger Firmen, definiert Qualität als strategischen Wettbewerbsvorteil und grenzt sich bewusst von klassischen Value-Ansätzen ab. Seine Bücher The Little Book That Builds Wealth und The Five Rules for Successful Stock Investing zählen heute zu den Standardwerken der fundamentalen Aktienanalyse. Sie verdeutlichen, wie Dorsey Unternehmen mit Burggräben erkennt, und warum nachhaltige Überrenditen immer aus struktureller Stärke entstehen. Weitere Informationen zu seinem Investment-Ansatz, findet sich auf seiner Homepage: https://dorseyasset.com/publications-commentary/ Inhaltsverzeichnis00:00 Intro00:51 Wer ist Pat Dorsey?02:03 Sein Konzept im Überblick02:40 Economic Moat/ Burggaben04:24 Reinvestieren05:19 Beispiel: Thermo Fisher07:02 Capital Allocation08:00 Portfolio Einblick von Pat Dorsey09:10 Dorsey Asset Management vs. S&P 50009:54 Börsen-Kompass Einblick10:52 Danke fürs Einschalten!

The blog postThis episode looks at how GE Aerospace CEO Larry Culp grounds Lean leadership in two fundamentals: safety and respect for people. Drawing on his recent appearance on the Gray Matter podcast, we explore how Culp applies the core habits of the Toyota Production System—not as slogans, but as daily practice.Culp traces his Lean development back to Danaher, where he learned kaizen directly from consultants trained by Toyota's Shingijutsu pioneers. That early exposure shaped his belief that improvement is a behavior, not a program. He still invites those same advisers, including Yukio Katahira, onto GE Aerospace's shop floors—reinforcing that the real expertise lives with the people doing the work.He describes how he “kaizens himself” after board meetings and plant visits, using the same PDSA cycle expected throughout the organization. His message is blunt: Lean fails when leaders try to drive improvement from conference rooms instead of going to the work.The conversation also highlights GE's SQDC focus—Safety and Quality before Delivery and Cost—and why Culp begins every leadership meeting with a safety moment. Given that three billion passengers fly each year on GE-powered aircraft, he frames safety as a responsibility, not a dashboard metric.Culp's turnaround work emphasizes cultural change as much as operational results. He's pushing GE from a finger-pointing culture toward a problem-solving culture, where issues are surfaced early and treated without blame. Psychological safety is essential to that shift.The throughline is simple and consistent: continuous improvement requires humble leadership, curiosity at every level, and a commitment to getting closer to the work. Culp's approach is a reminder that Lean endures not because of its tools, but because of the behaviors it cultivates.

With the flick of a switch on the 22nd of July 1929, Ireland was changed forever. When President W.T. Cosgrave turned on power at Ardnacrusha Hydroelectric Station, it kickstarted an exciting era for the new state. Inside the heart of Ireland's industrial revolution lies a story of extraordinary human achievement. A new book, entitled "Powerful People", unveils the remarkable lives of those who built, operated, and sustained the Ardnacrusha power station. For more on this, author Dan Danaher joined Alan Morrisey in-studio.

After a hiatus, the Radical Respect podcast has returned for the fall of 2025. In other exciting news, Kim's co-host from Season One, Ernest Adams, is back and joins Kim and Wesley as co-host of Season Four. Ernest is an executive from Nike, Danaher, Ralph Lauren and Ford Motor Company. Wesley has led developer relations and been a community manager at a number of tech companies. Kim is the author of Radical Candor and Radical Respect.This season, the three will discuss leadership challenges facing organizations large and small. Plus, they have a series of interesting guests lined up. In this kick-off episode, Kim, Wesley and Ernest talk about what they have been up to in the last few months and the state-of-play in the corporate world.  

In this week's episode of Dividend Talk, we're back with Q3 Earnings Roundup.We kick things off with Novo Nordisk shaking up half its board of directors, before covering two big dividend announcements from McDonald's and Amphenol. Then it's over to earnings, where we break down results from Germany's Mensch und Maschine, Danaher, Evolution Gaming, and Texas Instruments.We also review a listener portfolio from “Bella Dividends,” packed with high-yield European names, and share our thoughts on diversification, growth balance, and dividend safety.In the Q&A, we talk estate tax and brokers, the future of quarterly reports, DCF vs. dividend discount models, and stock-specific questions on Intel, TotalEnergies, Watsco, and GreenCoat UK.SEE YOU ON THE INSIDE!!Tickers discussed: NVO, MCD, APH, MUM.DE, DHR, EVO.ST, TXN, SHEL, IBM, TTE, INTL, WSO, RELAS, IBDR.MC, VWS.COJoin us:[Facebook] – Https://www.facebook.com/groups/dividendtalk⁠[Twitter] – @DividendTalk_ , @European_DG[Discord] – ⁠https://discord.gg/nJyt9KWAB5⁠[Premium Services] – ⁠https://dividendtalk.eu/download-your-free-samples/⁠[Malmo Meetup] – https://t.co/STgV1nMWKj

European bourses are mixed and have traded choppy throughout the morning; US equity futures are modestly lower, ahead of a slew of earnings.DXY is underpinned by the downbeat risk tone and easing credit concerns; JPY underperforms as Takaichi becomes Japanese PM.Global fixed paper are bid amid the softer risk tone and reports around AA rating criteria.Metals sell off as “debasement trade” loses momentum; Crude is essentially flat in choppy trade.Looking ahead, Canadian CPI (Sep), NBH Policy Announcement, CCP 4th Plenum (20th-23rd), Speakers including ECB's Nagel & Lagarde, Fed's Waller, BoE's Bailey & BreedenEarnings from Netflix, Intuitive, Texas Instruments, Capital One Financial, Coca-Cola, GE Aerospace, Elevance Health, Lockheed Martin, Philip Morris, RTX, General Motors, 3M, Nasdaq & Danaher.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

APAC stocks took their cues from the rally on Wall Street as the focus remained on US-China trade with some optimism following US President Trump's comments in which he stated that China has been respectful of them.US President Trump continued to tout a November 1st deadline for additional tariffs, he also reaffirmed that he will be meeting with Chinese President Xi and thinks they will reach a 'fantastic deal'.Japanese LDP leader Takaichi won the lower house vote (237 votes out of 465-seats) to become Japan's first female PM, as expected.European equity futures indicate a modestly positive cash market open with Euro Stoxx 50 futures up 0.1% after the cash market closed with gains of 1.3% on Monday.Looking ahead, highlights include UK PSNB (Sep), Canadian CPI (Sep), NBH Policy Announcement, CCP 4th Plenum (20th-23rd), Speakers including ECB's Nagel, Lane & Lagarde, Fed's Waller, BoE's Bailey & Breeden, Supply from UK & Germany,Earnings from Netflix, Intuitive, Texas Instruments, Capital One Financial, Coca-Cola, GE Aerospace, Elevance Health, Lockheed Martin, Philip Morris, RTX, General Motors, 3M, Nasdaq & Danaher.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über ein Oracle-Beben, eine Tesla-Enttäuschung und eine gekürzte Prognose bei BMW. Außerdem geht es um Seagate, Western Digital, Coreweave, Arista Networks, Vertiv, Dell, Tesla, BMW, Aurubis, Trilogy Metals, Recursion Pharmaceuticals, Absci, Oracle, Pfizer, Biontech, Moderna, AMD, IBM, L&G Pharma Breakthrough UCITS ETF (WKN: A2H9XR), Xtrackers MSCI Genomic Healthcare Innovation (WKN: DBX0R2), Aurubis, IBM, Alnylam, Bristol Myers Squib, Innocare, Incyte und Pharming Group, Lonza, AbbVie, Danaher, Vertex, VanEck Quantum Computing ETF (WKN: A418QM), VanEck Quantum Computing ETF (WKN: A418QM), Rigetti, Quantum Computing, D-Wave, IonQ, WisdomTree Quantum Computing ETF (WKN: A419HV), Alphabet, Honeywell, Microsoft und Deutsche Telekom. Wir freuen uns über Feedback an aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Der Börsen-Podcast Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article104636888/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über einen Gamechanger-Deal, Wall-Street-Rekorde trotz Shutdown und das fulminante Börsendebüt von Fermi. Außerdem geht es um Pfizer, Merck, Eli Lilly, Novo Nordisk, Vertex, Regeneron, Thermo Fisher, Repligen, Danaher, Boston Scientific, Abbott, Intuitive Surgical, Bayer, Merck, Salzgitter, Thyssenkrupp, Bitcoin, Solana, Ether, Sartorius, Palantir Technologies, Thales, L3Harris Technologies, RTX, Kratos Defense & Security Solutions, AeroVironment, DroneShield, Elbit Systems, Electro Optic Systems, Saab AB, Hensoldt, Mercury Systems, QinetiQ, Chemring Group, Cohort, Exail Technologies, Rocket Lab, Iridium Communications, BlackSky Technology, Electro Optic Systems, Leidos Holdings, CACI International, Parsons, Telos Corp, Leidos, SAIC, QinetiQ, Parsons VanEck Space Innovators ETF (WKN: A3DP9J), Invesco Defence Innovation ETF (WKN: A40J95), Global X Defence Tech ETF (WKN: A40E7A), Droneshield, Palantir, Red Cat Holdings. Wir freuen uns über Feedback an aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Der Börsen-Podcast Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article104636888/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

In this week's episode, we revisit our interview with Shawn McCormick. Shawn has 30 years of financial expertise and operational experience in the medical device and life sciences industry. Most recently, he was the Chief Financial Officer of Aldevron, a private equity-backed CDMO. Shawn joined Aldevron in 2020 and remained until February 2022, following the sale of the company to Danaher, Inc. in 2021. He served as the Chief Financial Officer of Tornier N.V. and Tornier, Inc. from September 2012 until the completion of the merger with Wright Medical in October 2015. He also served as Tornier's Principal Accounting Officer. Mr. McCormick served as Chief Operating Officer of Lutonix Inc. from April 2011 to February 2012, when Lutonix was sold to C.R.Bard.  He served as Chief Financial Officer and Senior Vice President of ev3, Inc. from January 2009 to July 2010 and as its Principal Accounting Officer. ev3 was sold to Covidien in July 2010. Mr. McCormick held various positions of increasing responsibility at Medtronic, Inc. from 1992 to 2009, including Vice President of Corporate Development from May 2008 to January 2009 and Vice President of Finance for the Spinal, Navigation, and ENT business from 2002 to 2007.  He has been a Director of Nevro Corp. since September 2014 and Inspire Medical Systems Inc. since January 2017. He also served on the board of Surmodics, Inc from December 2015 to December 2020 and the board of Entellus Medical from December 2014 to February 2018, when Entellus was sold to Stryker. Mr. McCormick serves as the Audit Committee Chair for both Nevro and Inspire and previously for Entellus. He also served as a Surmodics' audit committee and governance and nominating committee member. Mr. McCormick served on the board of LANX from August 2010 to November 2013, serving on the Compensation Committee and Audit Committee before LANX was sold to Biomet in November 2013.  Mr. McCormick is a Certified Public Accountant (non-active license). He holds a B.S. in Accounting from Arizona State University and an M.B.A. from the University of Minnesota's Carlson School of Management. 

Mark DeLuzio discusses the errors made when architecting the Danaher Business System and the things he would do differently today.

V novém díle MMA LETEM SVĚTEM jedeme bez brzd!

A lean office can either accelerate transformation or quietly undermine it. The difference often comes down to trust, leadership alignment, and a clear sense of purpose. Drawing on his time as the architect of the Danaher Business System, Mark shares hard-earned lessons about what makes a lean office succeed and where so many stumble. From CEOs treating their lean teams as spies to audits that destroy credibility, he explains the traps to avoid and the principles that matter. You'll hear why capability-building should be the core "product" of any lean office, how to prioritize resources around strategy, and why reporting directly to the CEO is so important. This episode is packed with practical insights for anyone running or working with a lean office, whether you're starting fresh or trying to course-correct.

The Fans WORST BJJ hot takes of the year: don't tap to pressure, cartwheel passes are trash, competing is “stupid,” and yes—we argue whether or not CJI will fail. Plus: did Mikey Musumeci sell out, will UFC BJJ take over, and is Danaher actually overrated?In this special episode Josh (@thejoshmckinney) is joined by executive producer Bryce Allen (@bryceallen_) as they tackle some of the hottest topics in modern day jiu jitsu.Jiu-Jitsu for Imbeciles (FREE)  BJJ Mental Models Kicksite FREE 30 Day TrialDatsusara 10% OFF with Promo Code “ISUCK”Master ANY Position in 6 WeeksJoin ⁠ISAJJ PRO (ALL of Josh's Courses in One Place)Join the Gi GazetteFollow the show on⁠ Instagram⁠⁠Check out the ISAJJ Youtube Channel⁠(00:00) Should you tap to pressure? (9:20) Cartwheel passes are Stupid.(17:00) No one teach Triangles Correctly(24:20) Competing is so so stupid (29:30) CJI WILL FAIL(39:10) Did Mikey Musumeci sell out?(47:20) UFC BJJ Will WIN?(55:25) Who will win CJI and Why is it Daisy Fresh?(1:07:25) Is Chasing Chicks at your gym kosher?(1:14:55) Can a female black belt gain respect from her male peers in Jiu Jitsu? / Should we Ban Women OR Men from Jiu Jitsu?(1:23:40) ISAJJ IS SEXIST??(1:26:20) BJJ is becoming Karate?(1:31:00) How Long Should you be a Brown Belt?(1:36:25) Danaher Sucks??

Sustainable Stock Picks for August 2025. Includes 12 articles featuring sustainable stock and green bond picks from mostly North America. By Ron Robins, MBA Transcript & Links, Episode 158, August 22, 2025 Hello, Ron Robins here. Welcome to my podcast episode 158, published on August 22, 2025, titled “Sustainable Stock Picks for August 2025.” Before I begin, I would like to inform you that I'm adjusting the release schedule for these podcasts. So, for the foreseeable future, this podcast will be released on the last Friday of every month. Hence, my next podcast will be on September 26th. This podcast is presented by Investing for the Soul. Investingforthesoul.com is your go-to site for vital global, ethical, and sustainable investing mentoring, news, commentary, information, and resources. Remember that you can find a full transcript and links to content, including stock symbols and bonus material, on this episode's podcast page at investingforthesoul.com/podcasts. Also, a reminder. I do not evaluate any of the stocks or funds mentioned in these podcasts, and I don't receive any compensation from anyone covered in these podcasts. Furthermore, I will reveal any investments I have in the investments mentioned herein. I have a great crop of 12 articles for you in this podcast! ------------------------------------------------------------- 12 Best Ethical Companies to Invest in 2025 The first article is by someone who has been on this podcast a few times. His name is Faheem Tahir, and his article is titled 12 Best Ethical Companies to Invest in 2025. It's found on fool.com. The methodology underlying his stock selection is fascinating and impressive. Here's some of what he has to say about it and brief quotes on each of his picks. “To curate our list of the 12 Best Ethical Companies to Invest in 2025, we used Ethisphere's list of ‘World's Most Ethical Companies'. Ethisphere's list relies on its Ethics Quotient, which evaluates companies based on their ethics, compliance, governance, and corporate responsibility across multiple criteria. We then used Insider Monkey's database to assess hedge fund sentiment on the shortlisted stocks. Finally, we ranked the stocks in ascending order based on the number of hedge funds holding stakes in the respective stocks as of Q1 2025. Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. (See more details here.) 12. Autodesk, Inc. (NASDAQ:ADSK) Number of Hedge Funds: 82 On July 23, Loop Capital started coverage on Autodesk with a ‘Hold' rating, setting a $320 price target… Autodesk is a global 3D design, engineering, construction, and entertainment software company, offers cutting-edge tools for everything from infrastructure to animation. 11. Workday, Inc. (NASDAQ:WDAY) Hedge Funds: 85 On July 14, 2025, Workday was selected by Seattle University as its partner… Serving global corporations, universities, and now, government entities, Workday offers AI-driven enterprise cloud applications, particularly for finance, HR, and student segments. 10. Eaton Corporation plc (NYSE:ETN) Hedge Funds: 85 Investor confidence is growing in Eaton Corporation with KeyBanc increasing its price target on the company from $355 to $410… The company has paid dividends every year since 1923… By designing and delivering electrical, hydraulic, and mechanical solutions, Eaton Corporation has made itself a leader in the intelligent power management solutions market, helping industries improve efficiency, safety, and sustainability. 9. Lam Research Corporation (NASDAQ:LRCX) Hedge Funds: 91 On July 21, 2025, UBS increased its price target on Lam Research Corporation from $95 to $120, maintaining a ‘Buy' rating… Lam Research Corporation, serving major foundries and integrated device manufacturers worldwide, manufactures advanced semiconductor processing equipment for chip production. 8. Intel Corporation (NASDAQ:INTC) Hedge Funds: 91 On July 24, 2025, Intel Corporation reported its financial performance for Q2, surprising Wall Street with a revenue of $12.86 billion that beat estimates of $11.92 billion. However, the company reported a net loss of $2.9 billion… Intel Corporation designs and manufactures computing products for tech companies worldwide. 7. Micron Technology, Inc. (NASDAQ:MU) Hedge Funds: 96 With rapid growth acceleration in the space economy, Micron Technology announced the launch of the industry's highest-density, radiation-tolerant SLC NAND flash memory on July 22, 2025. This memory chip is designed to survive space's harsh environment, marked by radiation, extreme temperatures, and vacuum pressure… Micron Technology is the only major U.S.-based memory maker, delivering advanced DRAM, NAND, and NOR solutions with its Micron and Crucial brands. 6. Pfizer Inc. (NYSE:PFE) Hedge Funds: 99 On July 24, 2025, Pfizer finalized the global licensing agreement with 3SBio, Inc…. Leveraging 3SBio's proprietary CLF2 platform, this innovative treatment enhances Pfizer's oncology pipeline and solidifies its competitive edge in cancer research… Operating globally, Pfizer discovers, develops, and sells biopharmaceuticals. 5. ServiceNow, Inc. (NYSE:NOW) Hedge Funds: 106 On July 23, 2025, ServiceNow reported financial results for Q2, beating guidance across all areas… On the same day as the earnings release, Jefferies increased its price target on ServiceNow from $1,025 to $1,150, maintaining a ‘Buy' rating. Stifel also increased its target to $1,200 on the same day. With its Now platform, ServiceNow offers a cloud-based solution for digital workflows globally. 4. Eli Lilly and Company (NYSE:LLY) Hedge Funds: 119 On July 18, Leerink Partners maintained its ‘Buy' rating on the company, citing growth potential through the GLP-1 receptor agonist (GLP-1RA) space… On the same day, Jefferies also maintained a ‘Buy' rating, setting its price target at $1,057… Operating globally, Eli Lilly and Company discovers, develops, and markets human pharmaceuticals. 3. Salesforce, Inc. (NYSE:CRM) Hedge Funds: 140 Salesforce is demonstrating a mixed performance as of the time of writing… Previously, on July 16, 2025, Citizens JMP maintained a ‘Market Outperform' rating on Salesforce with a price target of $430, citing future growth driven by the company's AI and cloud services. Offering Agentforce, Data Cloud, Salesforce Starter, and Tableau, Salesforce provides customer relationship management (CRM) technology, bridging companies and customers. 2. Mastercard Incorporated (NYSE:MA) Hedge Funds: 155 Ahead of its Q2 earnings, Truist decreased its price target on Mastercard Incorporated from $640 to $612, maintaining a ‘Buy' rating, reflecting its continued confidence in the stock… Mastercard Incorporated… offers transaction processing and other related products and services. 1. Visa Inc. (NYSE:V) Hedge Funds: 165 Truist Securities decreased its price target on Visa from $400 to $397, maintaining a ‘Buy' rating. Despite the price target reduction and recent underperformance of the fintech sector, the firm cited optimism regarding the company's strong fundamentals and promising outlook for the fintech sector. Visa is a global payment technology company, offering credit, debit, and prepaid card products, and VisaNet, a transaction processing network.” End quotes. ------------------------------------------------------------- Best Sustainable Companies to Own: 2025 Edition The second featured article is titled Best Sustainable Companies to Own: 2025 Edition. It's by Emelia Fredlick and Leslie P. Norton and seen on morningstar.com. (Note: follow the article link on this podcast episode's webpage to all 83 companies that Morningstar considers the best 2025 sustainable companies.) The article also highlights the three companies below. Here are some brief quotes from the authors. “Morningstar's research finds that the biggest ESG risk is in energy and utilities, with the smallest in technology and real estate. Morningstar Sustainalytics measures this with the Sustainalytics ESG Risk Rating… We didn't include valuations for these (83) companies. Rather, we focused on the criteria that set a company up for success in the long term. So, while not all these names can be considered a buy today, this can serve as a great watchlist… Data Source: Morningstar Direct as of Jun. 30, 2025. 1) RELX RELX UK-based RELX is a global provider of business information, analytics, and decision-making tools for professionals across industries. The firm generates revenue mainly by creating and selling access to curated information databases, analytics, and journals. Morningstar senior analyst Rob Hales assigns RELX a wide Morningstar Economic Moat Rating… Sustainalytics gives RELX an ESG Risk Management Rating of Strong. 2) Danaher DHR Danaher focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries. The firm aims to accelerate core growth at acquired companies, including Cytiva (formerly GE Biopharma), by making research and development and marketing-related investments… Sustainalytics gives Danaher an ESG Risk Management Rating of Strong. Morningstar senior analyst Julie Utterback assigns Danaher a wide economic moat. 3) Keysight Technologies KEYS Keysight Technologies is the leader in communications testing and measurement solutions. We think it has the strongest and broadest communications testing capabilities in the market across hardware, software, and services. Its wide moat rating, according to Morningstar senior analyst William Kerwin, owes to ‘intangible assets in the design of test and measurement equipment and software and switching costs for its portfolio of solutions.' Because of Keysight's strong ESG reporting and oversight of ESG issues, Sustainalytics gives the company an ESG Risk Management Rating of Strong.” End quotes. ------------------------------------------------------------- Top Wind Energy Stocks That Will Drive Long-Term Portfolio Growth The last article I'm covering is by Avisekh Bhattacharjee, for Zacks, and found on nasdaq.com. It's titled Top Wind Energy Stocks That Will Drive Long-Term Portfolio Growth. Here are some quotes from his article. “As clean energy technologies evolve, they are set to capitalize on growth opportunities and provide lucrative investment prospects. Our Wind Energy Screen helps identify stocks with high growth potential in this dynamic sector. 1) Arcosa ACA is a well-known provider of infrastructure-related products and services that serve the energy, construction and transportation markets. The company's Engineered Structures business provides wind towers, utility structures and telecommunication structures for wind power generation, electricity transmission and distribution, and wireless communication markets. This Zacks Rank #2 (Buy) company's Engineered Structures business continues to witness strong demand for its wind towers and engineered structures. Arcosa, Inc. (ACA): Free Stock Analysis Report. 2) Dominion Energy D together with its subsidiaries, produces and transports energy in the United States… The company has a portfolio of nearly 30,300 MW of electric-generating capacity, 10,600 miles of electric transmission lines and 79,700 miles of electric distribution lines… By 2035, the Zacks Rank #2 company also intends to make zero and low-emitting resources accountable for 99% of its electric generation. Dominion Energy Inc. (D): Free Stock Analysis Report. 3) Brookfield Renewable Partners BEP owns and operates several renewable power generating facilities. The company's power generating portfolio is comprised of hydroelectric generating, wind facilities and natural gas-fired plants. It has operations in the United States, Canada and Brazil. The Zacks Rank #2 company's exposure in wind and utility-scale solar generation sectors has been enabling it to capitalize on the growing opportunities across the renewable power sectors, with high cash margins and minimum fuel input cost. Brookfield Renewable Partners L.P. (BEP): Free Stock Analysis Report. 4) DTE Energy DTE is a diversified energy company that develops and manages energy-related businesses and services. The company has been investing steadily to enhance its renewable generation assets… Notably, this Zacks Rank #3 (Hold) company plans to reduce carbon emissions of its electric utility operations by 65% in 2028, 85% in 2032 and 90% by 2040 from the 2005 level. DTE Energy Company (DTE): Free Stock Analysis Report.” End quotes. ------------------------------------------------------------- More articles with Sustainable Stock & Bond Picks for August 2025 from around the world. 1. Title: Three Stocks For The Global Energy Transition on finimize.com. By Blair Couper. 2. Title: Unlocking Sustainable Income: Why the CIBC Sustainable Canadian Core Plus Bond ETF is a Must-Have for Resilient Portfolios on ainvest.com. By Wesley Park. 3. Title: Kroger a Top Socially Responsible Dividend Stock With 2.0% Yield (KR) on nasdaq.com. By BNK Invest. 4. Title: Biblically Aligned Fixed Income: The Case for the Inspire Corporate Bond Impact ESG ETF (IBD) in a Shifting Market Environment on ainvest.com. By Isaac Lane. 5. Title: Green Bonds and Sustainable Income Generation: Assessing VanEck Green Bond ETF (GRNB) as a Monthly Distribution Play in a Decarbonizing World on ainvest.com. By Samuel Reed. 6. Title: Enphase Energy: A Best-In-Class Balance Sheet Positioned To Thrive As Rates Decline on seekingalpha.com. By Gustavo Ribeiro. 7. Title: Baker Hughes Named Top Socially Responsible Dividend Stock with 2.1% Yield on ainvest.com. Author name unavailable. 8. Title: This Company Could Be the Amazon of AI Infrastructure on fool.com. By Harsh Chauhan. 9. Title: 11 Best Alternative Energy Stocks to Buy Right Now on insidermonkey.com. By Neha Gupta. ------------------------------------------------------------- Ending Comment These are my top news stories with their stock and fund tips for this podcast, “Sustainable Stock Picks for August 2025.” Please click the like and subscribe buttons wherever you download or listen to this podcast. That helps bring these podcasts to others like you. And please click the share buttons to share this podcast with your friends and family. Let's promote ethical and sustainable investing as a force for hope and prosperity in these deeply troubled times! Contact me if you have any questions. Thank you for listening. As I mentioned earlier, the release schedule for these podcasts is changing. So, for the foreseeable future, this podcast will be released on the last Friday of every month. So, my next podcast will be on September 26th. See you then. Bye for now.   © 2025 Ron Robins, Investing for the Soul

Today's guest is Amit Gupta, Chief Digital Officer, Life Sciences Manufacturing Industry, at Danaher. Amit returns to the program to share the operational playbook behind building enterprise-ready AI infrastructure. While AI headlines tend to focus on models, Amit emphasizes that success begins with what's underneath — the data. He outlines a four-part architecture that includes data aggregation, integration, transformation, and harnessing, walking listeners through how Danaher built a system that enables — not constrains — AI deployment. He also explores how tiered storage strategies address not just technical needs, but real-world challenges in compliance, cost control, and security. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the ‘AI in Business' podcast! This episode is sponsored by Pure Storage. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Many Lean transformations commence without understanding why, and the communications to employees are poor or nonexistent. Mark DeLuzio talks about this failure mode and why it is essential to answer the question, “What's in it for me?”

In today's enterprise landscape, many AI initiatives stall before delivering real business value—especially in service operations, where data lives in disconnected systems and frontline speed is critical. For Amit Gupta, Chief Digital Officer, Life Sciences Manufacturing Industry, at Danaher, overcoming these challenges requires a structured, business-first approach. On this episode of the AI in Business podcast, Amit shares how Danaher uses a 70/30 buy-versus-build strategy to accelerate time to value while maintaining flexibility. He details a step-by-step framework for identifying high-impact AI use cases, involving cross-functional teams early, and guiding projects from strategic concept to measurable results—what he calls moving from “strat to street.” Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the ‘AI in Business' podcast! This episode is sponsored by Aquant. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

When is it time to hone in your already cemented BJJ skills? Or when is it time to study up on the latest instructional by Danaher? Or maybe you are worried about mobility, and wanna try out our program. We believe you can make some gains in such little time, but we'd encourage you to stick with it for longer than 2 to see some serious improvement. We answer is all in todays QNA episode...----------------------BULLETPROOF SHIRTS: https://www.fanwear.com.au/products/core-bullet-proof-for-bjj-classic-tee----------------------Leave us a question for the next QNA episode:https://bulletproofforbjj.com/podcast---------------------Increase athleticism, reduce injuries and build a grapplers physique with the Bulletproof for BJJ App. Start your FREE 14 Day Trial today:iOS: https://apps.apple.com/us/app/bulletproof-for-bjj/id6444311790Android: https://play.google.com/store/apps/details?id=com.bulletproofforbjj&utm_source=na_MedStay Hydrated with Sodii the tastiest electrolytes in the Game! Get 15% OFF: BULLETPROOF15 https://sodii.com.au/bulletproof

This week on Everybody in the Pool, we're kicking off a mini-series on the ocean — the world's largest carbon sink, a source of food for nearly half the global population, home to 80% of animal life on Earth, and heating faster than expected. It's also a climate tech category full of untapped investment opportunities.Our guest is Kate Danaher, Managing Director at S2G Investments, where she co-leads the firm's oceans and seafood strategy. S2G is a growth-stage investment firm focused on food and agriculture, clean energy, and the ocean economy — and Kate's work connects all three for maximum systems-level impact.We talk about:

En este episodio especial de GRIPS AND MICS, nos sentamos con Joel y Cristian Amador, dos de los nombres más prometedores del Jiu Jitsu español, tras su seminario en Las Palmas. 🤼‍♂️🔥 👉 Hablamos sin filtros sobre: 💥 ¿Quién es el mejor de los dos hermanos? Rivalidad real y respeto mutuo. 🇺🇸 Su experiencia entrenando con John Danaher en EE.UU. 🥋 Cómo se preparan para los Trials del ADCC y lo que trajeron del sistema Danaher. 🧠 La importancia de entrenar con diversidad y tener mentalidad abierta. 💣 El salto viral de Cristian que revolucionó Instagram. 💪 Físico, técnica, ética de trabajo y lo que separa a los buenos de los mejores. 🔮 Predicciones para el próximo Give Me The Money y análisis de la escena competitiva actual. Un episodio cargado de detalles técnicos, anécdotas personales, historias de superación y la mentalidad necesaria para llegar a la élite del grappling. 🎙️ ¡Dale al play, comenta quién crees que ganaría entre los hermanos Amador, y no olvides suscribirte! 👇 ¿Estás de acuerdo con su visión del entrenamiento? ¿Has vivido algo similar en tu academia? ------------- ▶️ Suscríbete a nuestro canal: https://youtube.com/@brazilianjiujitsucanarias ☑️ Redes: * Facebook: https://www.facebook.com/brazilianjiujitsucanarias/ * Instagram: https://www.instagram.com/bjjcanarias ☑️ Podcast: 🎧 iTunes: https://podcasts.apple.com/podcast/grips-mics/id1469949945 🎧 Stitcher: https://www.stitcher.com/podcast/gripsmics 🎧 Spotify: https://open.spotify.com/show/3eP4LOW2TeGMOBfhm2zC2t 🎧 iVoox: https://www.ivoox.com/podcast-grips-mics_sq_f1705324_1.html ------------- ⏱️ Marcas de tiempo: 0:00 Introducción 1:27 No hay rival para Cristian 2:51 Acogida de seminarios 8:36 El mejor de los dos hermanos 17:02 Entrenando con John Danaher 20:34 Sentirse y estar en el top 22:16 Técnica viral de Cristian en el torneo Presa 24:25 Analizando luchas 26:17 Cómo saber si te funciona una técnica 29:01 Rodar con gente diferente 30:03 Detalles del seminario 30:57 Preparación del camp de trials de ADCC 37:50 El objetivo final de un grappler profesional 40:40 Polaris 42:05 Predicciones para el Give Me The Money 7 46:25 Despedida ✍️ Notas: G&M#285 - Joel Amador - Ahora sé dónde estoy y solo espero lo mejor de mí https://youtu.be/OoIh6GPTXaQ?si=5gADCkD_HK5boNNL GRIPS&MICS #88 - Santeri Lilius - Siempre puedes encontrar un punto débil que mejorar https://youtu.be/jKFvvx1G0X8?si=6K9ZG627qT6iG8sx

APAC stocks traded mixed after failing to sustain the early upward momentum seen at the open following the fresh record intraday highs on Wall St.White House Press Secretary Leavitt said they could see more tariff letters for August 1st.European equity futures indicate a lower cash market open with Euro Stoxx 50 future down 0.4% after the cash market finished with losses of 0.3% on Monday.DXY is steady, JPY is the marginal laggard as Japan returns from holiday, EUR/USD failed to hold onto the 1.17 handle.Looking ahead, highlights include US Richmond Fed Index, NBH Policy Announcement, Fed Chair Powell & Bowman, ECB's Lagarde, BoE's Bailey, Supply from UK & Germany.Earnings from Akzo Nobel, ASM International, Dassault Aviation, Julius Baer, Lindt, SAP, Intuitive, Capital One, Baker Hughes, Coca Cola, Lockheed Martin, Philip Morris, RTX, DR Horton, Northrop Gruman, Danaher, MSCI & Pulte.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

White House Press Secretary Leavitt said they could see more tariff letters for August 1st.European bourses are in the red and currently trade at session troughs, US equity futures also incrementally lower.DXY is flat awaiting fresh catalysts, whilst Antipodeans lag given the risk-tone.JGBs react to the election, bonds elsewhere have a bearish bias, Gilts lag.Crude moves in lockstep with risk while base metals remain cushioned.Looking ahead, US Richmond Fed Index, NBH Policy Announcement, Speakers including Fed Chair Powell & Bowman, ECB's Lagarde. Earnings from SAP, Intuitive, Capital One, Baker Hughes, Coca Cola, Lockheed Martin, Philip Morris, RTX, DR Horton, Northrop Gruman, Danaher, MSCI & Pulte.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

Eric Topol (00:05):Hello, it's Eric Topol from Ground Truths, and I've got some really exciting stuff to talk to you about today. And it's about the announcement for a new Center for pediatric CRISPR Cures. And I'm delight to introduce doctors Jennifer Doudna and Priscilla Chan. And so, first let me say this is amazing to see this thing going forward. It's an outgrowth of a New England Journal paper and monumental report on CRISPR in May. [See the below post for more context]Let me introduce first, Dr. Doudna. Jennifer is the Li Ka Shing Chancellor's Chair and a Professor in the departments of chemistry and of molecular and cell biology at the University of California Berkeley. She's also the subject of this book, one of my favorite books of all time, the Code Breaker. And as you know, the 2020 Nobel Prize laureate for her work in CRISPR-Cas9 genome editing, and she founded the Innovative Genomics Institute (IGI) back 10 years ago. So Jennifer, welcome.Jennifer Doudna (01:08):Thank you, Eric. Great to be here.Eric Topol (01:10):And now Dr. Priscilla Chan, who is the co-founder of the Chan Zuckerberg Initiative (CZI) that also was started back in 2015. So here we are, a decade later, these two leaders. She is a pediatrician having trained at UCSF and is committed to the initiative which has as its mission statement, “to make it possible to cure, prevent, and manage all diseases in this century.” So today we're going to talk about a step closer to that. Welcome, Priscilla.Priscilla Chan (01:44):Thank you. Thanks for having me.Eric Topol (01:46):Alright, so I thought we'd start off by, how did you two get together? Have you known each other for over this past decade since you both got all your things going?Jennifer Doudna (01:56):Yes, we have. We've known each other for a while. And of course, I've admired the progress at the CZI on fundamental science. I was an advisor very early on and I think actually that's how we got to know each other. Right, Priscilla?Priscilla Chan (02:11):Yeah, that's right. We got to know each other then. And we've been crisscrossing paths. And I personally remember the day you won the Nobel Prize. It was in the heart of the pandemic and a lot of celebrations were happening over Zoom. And I grabbed my then 5-year-old and got onto the UCSF celebration and I was like, look, this is happening. And it was really cool for me and for my daughter.Eric Topol (02:46):Well, it's pretty remarkable convergence leading up to today's announcement, but I know Priscilla, that you've been active in this rare disease space, you've had at CZI a Rare As One Project. Maybe you could tell us a bit about that.Priscilla Chan (03:01):Yeah, so at CZI, we work on basic science research, and I think that often surprises people because they know that I'm a pediatrician. And so, they often think, oh, you must work in healthcare or healthcare delivery. And we've actually chosen very intentionally to work in basic science research. In part because my training as a pediatrician at UCSF. As you both know, UCSF is a tertiary coronary care center where we see very unusual and rare cases of pediatric presentations. And it was there where I learned how little we knew about rare diseases and diseases in general and how powerful patients were. And that research was the pipeline for hope and for new discoveries for these families that often otherwise don't have very much access to treatments or cures. They have a PDF that maybe describes what their child has. And so, I decided to invest in basic science through CZI, but always saw the power of bringing rare disease patient cohorts. One, because if you've ever met a parent of a child with rare disease, they are a force to be reckoned with. Two, they can make research so much better due to their insights as patients and patient advocates. And I think they close the distance between basic science and impact in patients. And so, we've been working on that since 2019 and has been a passion of ours.Eric Topol (04:40):Wow, that's great. Now Jennifer, this IGI that you founded a decade ago, it's doing all kinds of things that are even well beyond rare diseases. We recently spoke, I know on Ground Truths about things as diverse as editing the gut microbiome in asthma and potentially someday Alzheimer's. But here you were very much involved at IGI with the baby KJ Muldoon. Maybe you could take us through this because this is such an extraordinary advance in the whole CRISPR Cures story.Jennifer Doudna (05:18):Yes, Eric. It's a very exciting story and we're very, very proud of the teamwork that went into making it possible to cure baby KJ of his very rare disease. And in brief, the story began back in August of last year when he was born with a metabolic disorder that prevented him from digesting protein, it's called a urea cycle disorder and rare, but extremely severe. And to the point where he was in the ICU and facing a very, very difficult prognosis. And so, fortunately his clinical team at Children's Hospital of Philadelphia (CHOP) reached out to Fyodor Urnov, who is the Director of Translational Medicine at the IGI here in the Bay Area. They teamed up and realized that they could quickly diagnose that child because we had an IRB approved here at the IGI that allowed us to collect patient samples and do diagnosis. So that was done.Jennifer Doudna (06:26):We created an off-the-shelf CRISPR therapy that would be targeted to the exact mutation that caused that young boy's disease. And then we worked with the FDA in Washington to make sure that we could very safely proceed with testing of that therapy initially in the lab and then ultimately in two different animal models. And then we opened a clinical trial that allowed that boy to be enrolled with, of course his parents' approval and for him to be dosed and the result was spectacular. And in fact, he was released from the hospital recently as a happy, healthy child, gaining lots of weight and looking very chunky. So it's really exciting.Eric Topol (07:16):It's so amazing. I don't think people necessarily grasp this. This timeline [see above] that we'll post with this is just mind boggling how you could, as you said Jennifer, in about six months to go from the birth and sequencing through cell specific cultures with the genome mutations through multiple experimental models with non-human primates even, looking at off-target effects, through the multiple FDA reviews and then dosing, cumulatively three dosing to save this baby's life. It really just amazing. Now that is a template. And before we go to this new Center, I just wanted to also mention not just the timeline of compression, which is unimaginable and the partnership that you've had at IGI with I guess Danaher to help manufacture, which is just another part of the story. But also the fact that you're not just even with CRISPR 1.0 as being used in approvals previously for sickle cell and β-thalassemia, but now we're talking about base editing in vivo in the body using mRNA delivery. So maybe you could comment on that, Jennifer.Jennifer Doudna (08:38):Yeah, very good point. So yeah, we used a version of CRISPR that was created by David Liu at the Broad Institute and published and available. And so, it was possible to create that, again, targeted to the exact mutation that caused baby KJ's disease. And fortunately, there was also an off-the-shelf way to deliver it because we had access to lipid nanoparticles that were developed for other purposes including vaccinations. And the type of disease that KJ suffered from is one that is treatable by editing cells in the liver, which is where the lipid nanoparticle naturally goes. So there were definitely some serendipity here, but it was amazing how all of these pieces were available. We just had to pull them together to create this therapy.Eric Topol (09:30):Yeah, no, it is amazing. So that I think is a great substrate for starting a new Center. And so, maybe back to you Priscilla, as to what your vision was when working with Jennifer and IGI to go through with this.Priscilla Chan (09:45):I think the thing that's incredibly exciting, you mentioned that at CZI our mission is to cure, prevent, and manage all disease. And when we talked about this 10 years ago, it felt like this far off idea, but every day it seems closer and closer. And I think the part that's super exciting about this is the direct connection between the basic science that's happening in CRISPR and the molecular and down to the nucleotide understanding of these mutations and the ability to correct them. And I think many of us, our imaginations have included this possibility, but it's very exciting that it has happened with baby KJ and CHOP. And we need to be able to do the work to understand how we can treat more patients this way, how to understand the obstacles, unblock them, streamline the process, bring down the cost, so that we better understand this pathway for treatment, as well as to increasingly democratize access to this type of platform. And so, our hope is to be able to do that. Take the work and inspiration that IGI and the team at CHOP have done and continue to push forward and to look at more cases, look at more organ systems. We're going to be looking in addition to the liver, at the bone marrow and the immune system.Priscilla Chan (11:17):And to be able to really work through more of the steps so that we can bring this to more families and patients.Eric Topol (11:30):Yeah, well it's pretty remarkable because here you have incurable ultra-rare diseases. If you can help these babies, just think of what this could do in a much broader context. I mean there a lot of common diseases have their roots with some of these very rare ones. So how do you see going forward, Jennifer, as to where you UC Berkeley, Gladstone, UCSF. I'm envious of you all up there in Northern California I have to say, will pull this off. How will you get the first similar case to KJ Muldoon going forward?Jennifer Doudna (12:13):Right. Well, IGI is a joint institute, as you probably know, Eric. So we were founded 10 years ago as a joint institute between UC Berkeley and UCSF. And now we have a third campus partner, UC Davis and we have the Gladstone Institute. So we've got an extraordinary group of clinicians and researchers that are coming together for this project and the Center to make it a success. We are building a clinical team at UCSF. We have several extraordinary leaders including Jennifer Puck and Chris Dvorak, and they are both going to be involved in identifying patients that could be enrolled in this program based on their diagnosis. And we will have a clinical advisory group that will help with that as well. So we'll be vetting patients probably right after we announce this, we're going to be looking to start enrolling people who might need this type of help.Eric Topol (13:18):Do you think it's possible to go any faster right now than the six months that it took for KJ?Jennifer Doudna (13:26):I think it could be. And here's the reason. There's a very interesting possibility that because of the type of technology that we're talking about with CRISPR, which fundamentally, and you and I have talked about this previously on your other podcast. But we've talked about the fact that it's a programmable technology and that means that we can change one aspect of it, one piece of it, which is a piece of a molecule called RNA that's able to direct CRISPR to the right sequence where we want to do editing and not change anything else about it. The protein, the CRISPR protein stays the same, the delivery vehicle stays the same, everything else stays the same. And so, we're working right now with FDA to get a platform designation for CRISPR that might allow streamlining of the testing process in some cases. So it'll obviously come down to the details of the disease, but we're hopeful that in the end it will be possible. And Priscilla and I have talked about this too, that as AI continues to advance and we get more and more information about rare diseases, we'll be able to predict accurately the effects of editing. And so, in some cases in the future it may be possible to streamline the testing process even further safely.Eric Topol (14:51):And I also would note, as you both know, well this administration is really keen on genome editing and they've had a joint announcement regarding their support. And in my discussions with the FDA commissioner, this is something they are very excited about. So the timing of the new Center for pediatric CRISPR Cures is aligned with the current administration, which is good to see. It's not always the case. Now going back, Priscilla, to your point that not just for the liver because delivery has been an issue of course, and we're going to try to get after a lot of these really rare diseases, it's going to go beyond there. So this is also an exciting new dimension of the Center, as you said, to go after the bone marrow for hematopoietic cells, perhaps other organs as well.Priscilla Chan (15:42):I mean what the expertise and feasibility, the immune system is going to be the next target. Jennifer Puck has been a pioneer in this work. She's the one who designed the newborn screen that will be the tool that picks up these patients as they are born. And I think the thing that's tremendous is the immune system, first of all is active in many, many diseases, not just these cases of children born with partial or absence of immune systems. And the course right now that these babies are left with is complete isolation and then a very long and arduous course of a bone marrow transplant with high morbidity and mortality. And even if after the transplant you have complications like graft versus host and immunosuppression. And so, the idea of being able to very specifically and with less the conditioning and morbidity and mortality of the treatment, being able to address this is incredible. And the implications for other diseases like blood cancers or other hematopoietic diseases, that's incredible. And that actually has an incredibly broad base of patients that can benefit from the learnings from these babies with severe combined immunodeficiencies.Eric Topol (17:10):Yeah, I think that goes back to a point earlier maybe to amplify in that previous CRISPR generation, it required outside the body work and it was extremely laborious and time consuming and obviously added much more to the expense because of hospitalization time. This is different. This is basically doing this inside the affected patient's body. And that is one of the biggest reasons why this is a big step forward and why we're so fortunate that your Center is moving forward. Maybe before we wrap up, you might want to comment, Jennifer on how you were able to bring in to build this platform, the manufacturing arm of it, because that seems to be yet another dimension that's helpful.Jennifer Doudna (18:01):Indeed, yes. And we were again fortunate with timing because you mentioned briefly that the IGI had set up a program with the Danaher Corporation back in January of last year. We call it our Beacon project. And it's focused on rare disease. And it's a really interesting kind of a unique partnership because Danaher is a manufacturing conglomerate. So they have companies that make molecules, they make proteins, they make RNA molecules, they make delivery molecules. And so, they were excited to be involved with us because they want to be a provider of these types of therapies in the future. And they can see the future of CRISPR is very exciting. It's expanding, growing area. And so, that agreement was in place already when the baby KJ case came to our attention. And so, what we're hoping to do with Danaher is again, work with them and their scientists to continue to ask, how can we reduce the cost of these therapies by reducing the cost of the molecules that are necessary, how to make them efficiently. We already, it's very interesting, Fyodor Urnov has toured their plant in North Dakota recently, and he found in talking to their engineers, there are a number of things that we can already see will be possible to do that are going to make the process of manufacturing these molecules faster and cheaper by a lot.Eric Topol (19:28):Wow.Jennifer Doudna (19:28):So it's a win-win for everybody. And so, we're really excited to do that in the context of this new Center.Eric Topol (19:36):Oh, that's phenomenal because some of these disorders you don't have that much time to work with before they could be brain or organ or vital tissue damage. So that's great to hear that. What you built here is the significance of it can't be under emphasized, I'll say because we have this May report of baby KJ, which could have been a one-off and it could have been years before we saw another cure of an ultra-rare disorder. And what you're doing here is insurance against that. You're going to have many more cracks at this. And I think this is the excitement about having a new dedicated Center. So just in closing, maybe some remarks from you Priscilla.Priscilla Chan (20:24):I just want to emphasize one point that's really exciting as we talk about these ultra-rare cases that they're often like one in a million. All these learnings actually help maximize the impact of lots of research across the sector that impacts actually everyone's health. And so, our learnings here from these patients that have very significant presentations that really can stand to benefit from any treatment is hopefully paving the way for many, many more of us to be able to live healthier, higher quality lives through basic science.Eric Topol (21:13):And over to you, Jennifer.Jennifer Doudna (21:15):Couldn't agree more. It's a really interesting moment. I think what we hope we are, is we're at sort of an inflection point where, as I mentioned earlier, all the pieces are in place to do this kind of therapeutic and we just need a team that will focus on doing it and pulling it together. And also learning from that process so that as Priscilla just said, we are ultimately able to use the same strategy for other diseases and potentially for diseases that affect lots of people. So it's exciting.Eric Topol (21:46):For sure. Now, if I could just sum up, this is now a decade past the origination of your work of CRISPR and how already at the first decade culminated in sickle cell disease treatment and β-thalassemia. Now we're into the second decade of CRISPR. And look what we've seen, something that was unimaginable until it actually happened and was reported just a little over a month ago. Now going back to Priscilla's point, we're talking about thousands of different rare Mendelian genomic disorders, thousands of them. And if you add them all up of rare diseases, we're talking about hundreds of millions of people affected around the world. So this is a foray into something much bigger, no less the fact that some of these rare mutations are shared by common diseases and approaches. So this really big stuff, congratulations to both of you and your organizations, the Innovative Genomics Institute and the Chan Zuckerberg Initiative for taking this on. We'll be following it with very deep interest, thank you.****************************************************Thanks for listening, reading and subscribing to Ground Truths.If you found this interesting PLEASE share it!That makes the work involved in putting these together especially worthwhile.Thanks to Scripps Research, and my producer, Jessica Nguyen, and Sinjun Balabanoff for video/audio support.All content on Ground Truths—its newsletters, analyses, and podcasts, are free, open-access.Paid subscriptions are voluntary and all proceeds from them go to support Scripps Research. They do allow for posting comments and questions, which I do my best to respond to. Please don't hesitate to post comments and give me feedback. Let me know topics that you would like to see covered.Many thanks to those who have contributed—they have greatly helped fund our summer internship programs for the past two years. Get full access to Ground Truths at erictopol.substack.com/subscribe

00:00 - 07:00 - Introduction, getting start at BJJ and social media 07:00 - 13:00 - Strength training and cults 13:00 - 15:15 - Conditioning15:15 - 24:10 - Understanding S&C for competitive sports24:10 - 29:00 - Understanding conditioning for BJJ 29:00 - 32:24 - MMA32:24 - 36:30 - Romans early days & Jiu Jitsu journey 36:30 - 45:00 - Training with Danaher and scheduling Jiu Jitsu 45:00 - 48:45 - Improving your Jiu Jitsu 48:45 - 56:00 - Competition VS Training room mindset56:00 - 57:33 - Closing notes Sponsors:Progress: https://www.progressjj-europe.com Use code RUNESCAPE at checkout for discount on any productsLess Impressed More Involved: https://outlierdb.com/ - use code RUNESCAPE for 50% off your first monthHow to work with us:Where to find Roman: https://www.instagram.com/romanjiujitsu/ Charles Strength Training Programs GET 7 DAY FREE MAT STRONG PROGRAM: https://mailchi.mp/charlesallanprice/mat-strong-landing-page BJJ Workouts Instructional: https://bjjfanatics.com/collections/new-releases/products/building-workouts-for-bjj-by-charles-allan-price 1:1 Coaching Inquiries: https://7kdbbkmkmsl.typeform.com/to/nSZHpCOL Hosted on Acast. See acast.com/privacy for more information.

In this episode, I'm joined by one of the most original and dynamic minds in Jiu-Jitsu today — Daniel Schuardt.A black belt competitor and coach currently training under John Danaher with the New Wave / Kingsway team in Austin, Texas, Daniel is the perfect blend of high-level athlete, thoughtful instructor, and unapologetically weird internet personality — and I mean that in the best way. He's also the head coach at Precision MMA in Australia.Daniel has competed around the globe, recently grabbing headlines with a dominant AIGA win. But what really sets Daniel apart is his ability to make the complicated stuff digestible — and hilarious. Whether he's explaining guard retention, breaking down strategy, or posting bizarre memes, Daniel keeps it real. His Instagram, @daniel_the_manchild, is a must-follow for anyone serious about learning while laughing.In this episode, we get into competition mindset, teaching methodology, training in the Danaher room, making Jiu-Jitsu more human and less dogmatic, and why being curious and creative on the mats can be a superpower.Links:https://www.instagram.com/daniel_the_manchild/⁠⁠https://www.instagram.com/precision_mma_official/⁠⁠https://www.precisionmma.com.au/⁠Buy Salt Electrolytes  @SaltElectrolytes  use code FWB for 15% off. https://saltelectrolytes.com/?fwb Become a VIP member for only .99 a month, get ad-free, uncensored, early episodes https://is.gd/GytgXMInstagram @foreverwhitebeltshow.Go buy your Forever White Belt swag at teespring.com/forever-white-belt.Linktree https://linktr.ee/foreverwhitebelt

Mark DeLuzio discusses the intangibles that made all the difference to the success of the Danaher Business System. He also discussed the main ingredients of DBS, the 5Ps: Purpose, Principles, People, Plan, Process.

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über Nvidias neuen KI-Billigchip, Hoffen auf das Pharma-Revival und was diese Woche sonst noch wichtig wird. Außerdem geht es um VanEck Uranium and Nuclear Technologies ETF (WKN: A3D47K), Uranium Energy, Oklo, Nuscale, Health Care Select Sector SPDR (WKN: A14QB2), CVS Health, United Health Group, Eli Lilly, Cigna, Danaher, Thermo Fisher Scientific sowie Gilead, Sandoz, J&J, Roche, Sanofi, VanEck Quantum Computing ETF (WKN: A418QM) Google, IBM, Microsoft, Sony, Boeing, Honeywell, IonQ, Rigetti und D-Wave. Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

What You'll Learn:In this episode, hosts Catherine McDonald, Patrick Adams, and guest Olaf Boettger discuss the importance of coaching for success, particularly in developing and mentoring emerging leaders. They highlight the need for leaders to unlearn harmful behaviors and adapt to new leadership styles.About the Guest:With 26 years of experience in Continuous Improvement, our guest brings a wealth of knowledge and a unique perspective shaped by leadership roles at two of the world's most respected organizations: Procter & Gamble and Danaher. He spent 10 years at P&G, including time as a Brand Manager, and 16 years at Danaher, where he served in a variety of critical roles. His expertise spans over three core areas, Business Leadership, Continuous Improvement Leadership, and Executive Coaching. Whether driving operational excellence, leading transformation, or coaching executives, he brings a powerful blend of strategy, systems thinking, and people development to the table.Links:Click Here For Olaf Boettger LinkedIn

Cramer says he expects this beaten-down FinTech stock to make a comeback. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market's biggest headlines. Signup here: cnbc.com/morningtake CNBC Investing Club Disclaimer

It was a moment that would shape Erik Swenson's approach to finance forever. As a co-op student at Northeastern University, he found himself in front of a room full of engineers, presenting financial metrics he had carefully compiled. When the meeting ended, one of the engineers approached him and said, “That was interesting, but it doesn't mean anything to me. I make the product.” The comment struck a nerve. Driving home that evening, Swenson couldn't shake the realization—numbers alone don't drive a business; they need to connect to the people building it.That early lesson in financial storytelling set the foundation for a career built on bridging finance with operations. Swenson tells us his path wasn't a straight line—he originally pursued computer science before pivoting to economics and then accounting. After early roles in financial analysis, he spent 15 years moving through finance leadership positions at Danaher, where he sharpened his ability to translate financial insights into business decisions.When IDT tapped him to be CFO in 2018, Swenson faced a challenge that tested his adaptability. As he tells us, the company had a strong accounting foundation but needed deeper financial analysis to support its innovation-driven growth. He immediately set to work embedding finance into IDT's decision-making, ensuring the function wasn't just reporting numbers but helping shape the company's strategic direction. “It's not just about getting the numbers right,” Swenson explains, “it's about making sure those numbers mean something for the business.”

This week we're talking to Dr. James Danaher about his newest book, "A Deeper Life". We talk about Jesus, the Gospel, and how the message of the Gospel isn't about becoming more righteous, but remembering and awakening to who we have always been. Enjoy! SHOW NOTES: JAMES DANAHER: https://www.amazon.com/stores/James-P.-Danaher/author/B001JS5LRY?ref=sr_ntt_srch_lnk_1&qid=1738764267&sr=8-1&isDramIntegrated=true&shoppingPortalEnabled=true A DEEPER LIFE: https://www.amazon.com/Deeper-Life-Mysticism-Jesus-Sermon-ebook/dp/B0D4R95WTN?ref_=ast_author_dp&dib=eyJ2IjoiMSJ9.kw8V28y42kAn1LFjLyYl72-LJ_vZ44lo1ci_s6fYLsbuk3otSoWXAgfnEtA5IuIYDrWbI-eBRrPnJtfbxEn6bsqW2HcNFvQefjesFQpdHmICDgSK8Elk2fA-DrgQ3wFts-os1HjpYPXVpO8BYPmeHw.kkb6W39IZBrmq-AUrrXw1J6J_XqosGnX8ou9C2aP6F0&dib_tag=AUTHOR MY BOOK: https://www.amazon.com/Emerging-Rubble-Stories-Shattered-Relationships/dp/B0C7T5TJD4/ref=sr_1_1?crid=2B051GGV2WCSI&keywords=glenn+siepert&qid=1700157759&sprefix=glenn+%2Caps%2C399&sr=8-1 SUBSTACK / BLOG: https://whatifproject.substack.com/ ART STUDIO: https://www.whatifproject.net/art SUPPORT THE SHOW: https://www.whatifproject.net/support SPECIAL MUSIC: FLYIN (Artist) / GO HIGHER (Song Name) / courtesy of epidemicsound.com

Jim and Jeff discuss the positive outlook for this cybersecurity stock. They also discuss why they sold this life sciences stock. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market's biggest headlines. Signup here: cnbc.com/morningtake CNBC Investing Club Disclaimer

"They're writing a constitution for the entire planet that will impact everybody, every biological system, every crop, and nobody knows anything about them because they operate in secret.." -Kevin Danaher, co-founder of Global Exchange and anti-WTO organizer On November 30th, 1999, a huge movement spanning labor, environment, human rights, fair trade and more literally shut down the World Trade Organization in Seattle. It was milestone in the growing anti-corporate globalization movement and challenged the inevitability of neo-liberalism. In a new series of episodes, we're looking at the 25th anniversary of the "Battle in Seattle" talking with a number of people who participated in the organizing and its aftermath. In this episode, we talk with co-founder of Global Exchange and anti-WTO protest organizer Kevin Danaher. Bio// Dr. Kevin Danaher is a co-founder of Global Exchange (1988), co-founder of FairTradeUSA (1997), founder and Executive Co-Producer of the Green Festivals (2001-2013), founder of the Green Guardians, and is a lifelong educator. His 1983 PhD in sociology from the University of California at Santa Cruz was based on his dissertation, “The Political Economy of U.S. Policy Toward South Africa.” He was very active in the anti-apartheid movement. Dr. Danaher has published numerous articles and is the author and/or editor of thirteen books, including: The Green Festival Reader: Fresh Ideas from Agents of Change; and Building the Green Economy: Success Stories from the Grassroots. His most recent book, The Two Globalizations, is a free PDF download at kevindanaher.org. He has an article, “On Becoming Solutionaries,” in the May 2020 issue of The Solutions Journal. --------------------- Outro- "Green and Red Blues" by Moody Links// + Global Exchange (https://globalexchange.org/) + Kevin's website (https://www.kevindanaher.org/) Follow Green and Red// +G&R Linktree: ⁠⁠⁠https://linktr.ee/greenandredpodcast⁠⁠⁠ +Our rad website: ⁠⁠⁠https://greenandredpodcast.org/⁠⁠⁠ + Join our Discord community (https://discord.gg/uvrdubcM) +NEW: Follow us on Substack (https://greenandredpodcast.substack.com) +NEW: Follow us on Bluesky (https://bsky.app/profile/podcastgreenred.bsky.social) Support the Green and Red Podcast// +Become a Patron at https://www.patreon.com/greenredpodcast +Or make a one time donation here: ⁠⁠⁠https://bit.ly/DonateGandR⁠⁠⁠ Our Networks// +We're part of the Labor Podcast Network: ⁠⁠⁠https://www.laborradionetwork.org/⁠⁠ +We're part of the Anti-Capitalist Podcast Network: linktr.ee/anticapitalistpodcastnetwork +Listen to us on WAMF (90.3 FM) in New Orleans (https://wamf.org/) This is a Green and Red Podcast (@PodcastGreenRed) production. Produced Bob (@bobbuzzanco) and Scott (@sparki1969). Edited by Scott.